PDH Kinase Inhibitors: A Novel Therapy for Type II Diabetes?

Biochemical Society Transactions - United Kingdom
doi 10.1042/bst0330367
Full Text
Abstract

Available in full text

Categories
Biochemistry
Date
Authors
Publisher

Portland Press Ltd.

Related search

Tyrosine Kinase Inhibitors for Diabetes

Science-Business eXchange
2008English

Affinity-Based Probes Based on Type II Kinase Inhibitors

Journal of the American Chemical Society
BiochemistryColloidCatalysisChemistrySurface Chemistry
2012English

Gene Therapy for Type 1 Diabetes: A Novel Approach for Targeted Treatment of Autoimmunity

Journal of Clinical Investigation
Medicine
2004English

Dihydropyrrolopyrazole Transforming Growth Factor-B Type I Receptor Kinase Domain Inhibitors: A Novel Benzimidazole Series With Selectivity Versus Transforming Growth Factor-B Type II Receptor Kinase and Mixed Lineage Kinase-7

English

Novel Thioredoxin Inhibitors for Breast Cancer Therapy

2002English

Personalized Therapy of Tyrosine Kinase Inhibitors

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2013English

Fetuin-A: A Biomarker for Type II Diabetes Mellitus

International Journal of Biomedical Materials Research
2017English

Cyclophilin Inhibitors as a Novel HCV Therapy

Viruses
VirologyInfectious Diseases
2010English

Designing Visfatin Inhibitors to Limit Its Insulin Mimcy and Type II Diabetes.

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy